Opioid-Induced Constipation Treatment Market - Global Outlook and Forecast 2021-2027

Code: RW00014555857
Market Monitor Global
Oct-2021
Life Sciences
92 Pages

This report contains market size and forecasts of Opioid-Induced Constipation (OIC) Treatment in Global, including the following market information:
Global Opioid-Induced Constipation (OIC) Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Opioid-Induced Constipation (OIC) Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid-Induced Constipation (OIC) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioid-Induced Constipation (OIC) Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Opioid-Induced Constipation (OIC) Treatment Market Segment Percentages, By Type, 2020 (%)
Oral
Parenteral (Subcutaneous Injection)

China Opioid-Induced Constipation (OIC) Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Opioid-Induced Constipation (OIC) Treatment Market Segment Percentages, By Application, 2020 (%)
Drug Store
Independent Pharmacies
Hospital Pharmacies

Global Opioid-Induced Constipation (OIC) Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Opioid-Induced Constipation (OIC) Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Opioid-Induced Constipation (OIC) Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Opioid-Induced Constipation (OIC) Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Opioid-Induced Constipation (OIC) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid-Induced Constipation (OIC) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opioid-Induced Constipation (OIC) Treatment Overall Market Size
2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size: 2021 VS 2027
2.2 Global Opioid-Induced Constipation (OIC) Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Opioid-Induced Constipation (OIC) Treatment Players in Global Market
3.2 Top Global Opioid-Induced Constipation (OIC) Treatment Companies Ranked by Revenue
3.3 Global Opioid-Induced Constipation (OIC) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Opioid-Induced Constipation (OIC) Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Opioid-Induced Constipation (OIC) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Opioid-Induced Constipation (OIC) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Opioid-Induced Constipation (OIC) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Opioid-Induced Constipation (OIC) Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Opioid-Induced Constipation (OIC) Treatment Market Size Markets, 2021 & 2027
4.1.2 Oral
4.1.3 Parenteral (Subcutaneous Injection)
4.2 By Type - Global Opioid-Induced Constipation (OIC) Treatment Revenue & Forecasts
4.2.1 By Type - Global Opioid-Induced Constipation (OIC) Treatment Revenue, 2016-2021
4.2.2 By Type - Global Opioid-Induced Constipation (OIC) Treatment Revenue, 2022-2027
4.2.3 By Type - Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Opioid-Induced Constipation (OIC) Treatment Market Size, 2021 & 2027
5.1.2 Drug Store
5.1.3 Independent Pharmacies
5.1.4 Hospital Pharmacies
5.2 By Application - Global Opioid-Induced Constipation (OIC) Treatment Revenue & Forecasts
5.2.1 By Application - Global Opioid-Induced Constipation (OIC) Treatment Revenue, 2016-2021
5.2.2 By Application - Global Opioid-Induced Constipation (OIC) Treatment Revenue, 2022-2027
5.2.3 By Application - Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Opioid-Induced Constipation (OIC) Treatment Market Size, 2021 & 2027
6.2 By Region - Global Opioid-Induced Constipation (OIC) Treatment Revenue & Forecasts
6.2.1 By Region - Global Opioid-Induced Constipation (OIC) Treatment Revenue, 2016-2021
6.2.2 By Region - Global Opioid-Induced Constipation (OIC) Treatment Revenue, 2022-2027
6.2.3 By Region - Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Opioid-Induced Constipation (OIC) Treatment Revenue, 2016-2027
6.3.2 US Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.3.3 Canada Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.3.4 Mexico Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Opioid-Induced Constipation (OIC) Treatment Revenue, 2016-2027
6.4.2 Germany Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.4.3 France Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.4.4 U.K. Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.4.5 Italy Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.4.6 Russia Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.4.8 Benelux Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Opioid-Induced Constipation (OIC) Treatment Revenue, 2016-2027
6.5.2 China Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.5.3 Japan Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.5.4 South Korea Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.5.6 India Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Opioid-Induced Constipation (OIC) Treatment Revenue, 2016-2027
6.6.2 Brazil Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.6.3 Argentina Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Revenue, 2016-2027
6.7.2 Turkey Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.7.3 Israel Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
6.7.5 UAE Opioid-Induced Constipation (OIC) Treatment Market Size, 2016-2027
7 Players Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Major Product Offerings
7.1.4 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Revenue in Global (2016-2021)
7.1.5 GlaxoSmithKline Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Major Product Offerings
7.2.4 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Revenue in Global (2016-2021)
7.2.5 AstraZeneca Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Opioid-Induced Constipation (OIC) Treatment Major Product Offerings
7.3.4 Pfizer Opioid-Induced Constipation (OIC) Treatment Revenue in Global (2016-2021)
7.3.5 Pfizer Key News
7.4 S.L.A. Pharma
7.4.1 S.L.A. Pharma Corporate Summary
7.4.2 S.L.A. Pharma Business Overview
7.4.3 S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Major Product Offerings
7.4.4 S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Revenue in Global (2016-2021)
7.4.5 S.L.A. Pharma Key News
7.5 AIKO Biotechnology
7.5.1 AIKO Biotechnology Corporate Summary
7.5.2 AIKO Biotechnology Business Overview
7.5.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Major Product Offerings
7.5.4 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Revenue in Global (2016-2021)
7.5.5 AIKO Biotechnology Key News
7.6 Cubist Pharmaceuticals
7.6.1 Cubist Pharmaceuticals Corporate Summary
7.6.2 Cubist Pharmaceuticals Business Overview
7.6.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Major Product Offerings
7.6.4 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Revenue in Global (2016-2021)
7.6.5 Cubist Pharmaceuticals Key News
7.7 Salix Pharmaceuticals
7.7.1 Salix Pharmaceuticals Corporate Summary
7.7.2 Salix Pharmaceuticals Business Overview
7.7.3 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Major Product Offerings
7.4.4 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Revenue in Global (2016-2021)
7.7.5 Salix Pharmaceuticals Key News
7.8 Takeda Pharmaceutical
7.8.1 Takeda Pharmaceutical Corporate Summary
7.8.2 Takeda Pharmaceutical Business Overview
7.8.3 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Major Product Offerings
7.8.4 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Revenue in Global (2016-2021)
7.8.5 Takeda Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Opioid-Induced Constipation (OIC) Treatment Market Opportunities & Trends in Global Market
Table 2. Opioid-Induced Constipation (OIC) Treatment Market Drivers in Global Market
Table 3. Opioid-Induced Constipation (OIC) Treatment Market Restraints in Global Market
Table 4. Key Players of Opioid-Induced Constipation (OIC) Treatment in Global Market
Table 5. Top Opioid-Induced Constipation (OIC) Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Opioid-Induced Constipation (OIC) Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Opioid-Induced Constipation (OIC) Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Opioid-Induced Constipation (OIC) Treatment Product Type
Table 9. List of Global Tier 1 Opioid-Induced Constipation (OIC) Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid-Induced Constipation (OIC) Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE